*Created on 2023-11-06, 13:15* 

---
- A recombinant, virus vector-based gene therapy used to treat spinal muscular atrophy. 
- It delivers a normal copy of the SMN1 gene, which encodes human survival motor neuron (SMN) protein, to the neurons of the anterior horns of the spinal cord
- An agent based on an adeno-associated virus 9-based vector that carries a normal copy of SMN1 to the lower motor neurons of the spinal cord
- Should be administered intravenously once in a lifetime 